Wave Life Sciences Ltd. (WVE)

Finanzdaten der Wave Life Sciences Ltd.-Aktie (WVE)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	56.85% 12.54	29.06	49.21	22.11	12.93
Operating Expenses	1.55% 47.00	47.74	44.77	45.58	43.21
Benefits Costs and Expenses	2.68% 44.10	45.31	42.64	43.21	40.33
Costs And Expenses	2.68% 44.10	45.31	42.64	43.21	40.33
Operating Income/Loss	84.44% -34.46	-18.68	4.444	-23.47	-30.29
Nonoperating Income/Loss	19.54% 2.90	2.426	2.131	2.369	2.88
Income/Loss From Continuing Operations Before Tax	94.13% -31.56	-16.26	6.575	-21.10	-27.41
Income Tax Expense/Benefit	-	-	-0.677	-	-
Income/Loss From Continuing Operations After Tax	94.13% -31.56	-16.26	7.252	-21.10	-27.41
Net Income/Loss	94.13% -31.56	-16.26	7.252	-21.10	-27.41
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	8,144% 129.27	1.568	106.03	105.46	102.06
Diluted Average Shares	8,144% 129.27	1.568	106.98	105.46	102.06
Basic Earnings Per Share	60.00% -0.24	-0.15	0.07	-0.20	-0.27
Diluted Earnings Per Share	60.00% -0.24	-0.15	0.07	-0.20	-0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-0.257	-	-